These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15586810)

  • 21. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
    Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
    J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New ceramides from sea sponge Oceanapia sp].
    Gusiĭ AG; Makar'eva TN; Svetashev VI; Denisenko vA; Dmitrenok PS; Pokashevich EV; Santalova EA; Krasokhin VB; Stonik VA
    Bioorg Khim; 2006; 32(3):320-7. PubMed ID: 16808175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
    Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
    Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
    Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
    Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
    Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
    Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
    Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4657-63. PubMed ID: 19604694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA; Mikhailidis DP
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liquid phase method of synthesizing polyamides binding DNA using oligocarboxamide blocks].
    Sniiakov AN; Feshchenko MV; Riabinin VA
    Bioorg Khim; 2004; 30(1):110-2. PubMed ID: 15040312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The synthesis and antiherpetic activity of acyclovir phosphonate esters].
    Ias'ko MV; Ulanova NIu; Andronova VL; Ivanov AV; Karpenko IL; Kukhanova MK; Galegov GA; Skoblov IuS
    Bioorg Khim; 2004; 30(6):599-606. PubMed ID: 15586811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of nitric oxide-releasing derivatives of 3-n-butylphthalide as anti-platelet agents.
    Li Y; Wang X; Fu R; Yu W; Wang X; Lai Y; Peng S; Zhang Y
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4210-4. PubMed ID: 21684163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polymethylene derivatives of nucleic bases with omega-functional groups: IV. [7-(2-oxocyclohexyl)-7-oxoheptyl]purines].
    Kritsin AM; Versalainen J; Komissarov VV
    Bioorg Khim; 2005; 31(3):288-94. PubMed ID: 16004387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
    Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
    Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
    Seyberth T; Voss S; Brock R; Wiesmüller KH; Jung G
    J Med Chem; 2006 Mar; 49(5):1754-65. PubMed ID: 16509590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of 11-deoxymisoprostol ethyl ether sodium salt on thrombocyte aggregation and prothrombin time].
    Gabdrakhmanova SF; Makara NS; Sapozhnikova TV; Baschenko NZh; Nazarov VS; Zarudiĭ FS
    Eksp Klin Farmakol; 2008; 71(2):40-2. PubMed ID: 18488906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.